Hunter Syndrome Treatment Market: Growth Trends & Future Outlook
Introduction to the Hunter Syndrome Treatment Market
The Hunter syndrome treatment market is gaining momentum due to advancements in enzyme replacement therapy (ERT), gene therapy, and novel drug development. Hunter syndrome, also known as mucopolysaccharidosis type II (MPS II), is a rare genetic disorder caused by a deficiency of the iduronate-2-sulfatase (IDS) enzyme, leading to severe complications in the central nervous system, heart, and other organs.
Get More Details:- https://www.reportprime.com/hu....nter-syndrome-treatm
पसंद करना
टिप्पणी
शेयर करना
